(401) 223-1309

Eastern Allergy Conference
Eastern Allergy Conference
  • Home
  • Conference Registration
  • Meeting Program
  • Exhibitor Registration
  • Hotel Information
  • Corporate Sponsorship
  • Promotional Opportunities
  • 2020 Presentations
  • Abstract Submissions
  • In Memoriam
  • Meeting Abstracts
  • About EAC
  • Past and Future Meetings
  • Schedule of Events
  • COVID 19
  • EAC Asthma Content
  • More
    • Home
    • Conference Registration
    • Meeting Program
    • Exhibitor Registration
    • Hotel Information
    • Corporate Sponsorship
    • Promotional Opportunities
    • 2020 Presentations
    • Abstract Submissions
    • In Memoriam
    • Meeting Abstracts
    • About EAC
    • Past and Future Meetings
    • Schedule of Events
    • COVID 19
    • EAC Asthma Content

(401) 223-1309


  • Home
  • Conference Registration
  • Meeting Program
  • Exhibitor Registration
  • Hotel Information
  • Corporate Sponsorship
  • Promotional Opportunities
  • 2020 Presentations
  • Abstract Submissions
  • In Memoriam
  • Meeting Abstracts
  • About EAC
  • Past and Future Meetings
  • Schedule of Events
  • COVID 19
  • EAC Asthma Content

Find out more

EAC Asthma Content

EAC Published Asthma Content

Upcoming 2020 Asthma Lectures

Upcoming 2020 Asthma Lectures

  

Severe asthma: A focus on diagnosis risk assessment and costs
Oppenheimer, John


Comorbidities associated with severe asthma
Patel, Gayatri B.; Peters, Anju T.


Biomarkers in the context of managing severe asthma
Stanley J. Szefler, MD 


Targets in the use of biologics for asthma
John Oppenheimer, MD

  

Pearls and pitfalls in the diagnosis of cough variant asthma
William M. Corrao, MD

Upcoming 2020 Asthma Lectures

Upcoming 2020 Asthma Lectures

Upcoming 2020 Asthma Lectures

Assessing the unmet need for current and future biologics in pediatric asthma management*

Leonard Bacharier, MD


Pro/Con Debate:

PRO: Anti-IL5 therapies are biologics of choice for 

severe eosinophilic asthma*

Mario Castro, MD

CON: Anti-IL5 therapies are NOT biologics of choice for 

severe eosinophilic asthma*

Rey Panettieri, MD


Combinationics/beta-agonist inhaler as reliever therapy: 

FDA vs new guidelines*

Leonard Bacharier, MD


*Presented at the Eastern Allergy Conference, August 16-18, 2020

Copyright © 2021 Eastern Allergy Conference - All Rights Reserved.

Powered by GoDaddy

  • Conference Registration
  • Meeting Program
  • Exhibitor Registration
  • Hotel Information
  • Corporate Sponsorship
  • Promotional Opportunities
  • EAC Asthma Content